CAITLIN SURIANO: Open Payments
NPI 1124594205 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$129 in 6 payments from 4 companies in 2025. Trend: 2023 $597 · 2024 $0 · 2025 $129
Food & beverage: $129
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Optinose US, Inc. | 1 | $17 |
Products named: NUCALA, TRELEGY ELLIPTA, DUPIXENT, FASENRA, Xhance.
Industry payments across AZ — which companies pay providers there.
